Intermittent androgen suppression

被引：16
作者：
Pether, M [1 ]
Goldenberg, SL [1 ]
机构：
[1] Univ British Columbia, Dept Surg, Div Urol, VGH,Prostate Ctr, Vancouver, BC V6T 1W5, Canada
来源：
BJU INTERNATIONAL | 2004年 / 93卷 / 03期
关键词：
prostate cancer; androgens; intermittent therapy; outcome; survival;
D O I：
10.1111/j.1464-410X.2004.04597.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 261
页数：4
相关论文
共 36 条
  • [1] Adib RS, 1997, BRIT J UROL, V79, P235
  • [2] AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO
  • [3] 2-Z
  • [4] Intermittent androgen suppression in the treatment of metastatic prostate cancer
    Bouchot, O
    Lenormand, L
    Karam, G
    Prunet, D
    Gaschignard, N
    Malinovsky, JM
    Buzelin, JM
    [J]. EUROPEAN UROLOGY, 2000, 38 (05) : 543 - 549
  • [5] BRUCHOVSKY N, 1990, CANCER RES, V50, P2275
  • [6] BRUCHOVSKY N, 1995, UROLOGE A, V34, P389
  • [7] BRUCHOVSKY N, 1996, CANC MED, P1133
  • [8] Intermittent androgen suppression in the management of prostate cancer
    Crook, JM
    Szumacher, E
    Malone, S
    Huan, S
    Segal, R
    [J]. UROLOGY, 1999, 53 (03) : 530 - 534
  • [9] Osteoporosis after orchiectomy for prostate cancer
    Daniell, HW
    [J]. JOURNAL OF UROLOGY, 1997, 157 (02) : 439 - 444
  • [10] DENIS L, 1993, CANCER, V72, P3888, DOI 10.1002/1097-0142(19931215)72:12+<3888::AID-CNCR2820721726>3.0.CO
1234